← Back
$ACAD All transactions

ACADIA PHARMACEUTICALS INC

▼ SELL 10b5-1 Plan

$ Value

$50K

Shares

2,000

Price

$25

Filed

May 19

Insider

Name

Schneyer Mark C. / Kihara James

Title

EVP, CHIEF FINANCIAL OFFICER

CIK

0001899977

Roles

Officer

Transaction Details

Transaction Date

2025-05-16

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

62,130

Footnotes

The sales reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024. | Includes 1,357 shares of the Issuer's common stock acquired by the Reporting Person on May 15, 2025 pursuant to an employee stock purchase plan.

Filing Info

Accession No.

0001415889-25-013741

Form Type

4

Issuer CIK

0001070494

Schneyer Mark C. / Kihara James's History

Date Ticker Type Value
2026-04-07 ACAD $60K
2026-04-05 ACAD M
2026-04-05 ACAD M $0
2026-03-26 ACAD $69K
2026-03-26 ACAD $804
2026-03-25 ACAD $90K
2026-03-25 ACAD M
2026-03-25 ACAD M $0
2026-03-24 ACAD M
2026-03-24 ACAD M $0

Other Insiders at ACAD (90d)

Insider Bought Sold Last
Rhodes Jennifer J
EVP, CHIEF LEGAL OFFICER, SEC
$83K 2026-03-25
Kihara James
PRINCIPAL ACCOUNTING OFFICER
$65K 2026-04-07
Owen Adams Catherine
Chief Executive Officer
$250K 2026-03-25
Thompson Elizabeth H.Z.
EVP, Head of Research & Dev
$74K 2026-03-25
Schneyer Mark C.
EVP, CHIEF FINANCIAL OFFICER
$219K 2026-04-07